Back
Surgery Partners Stock Price Chart

While Jobs Disappear, Phones Are Picking Up The Slack
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
SGRY
Surgery Partners
Last Price:
$23.61
Seasonality Move:
0.2%
7 Day Trial
ALL ACCESS PASS
$
7

AI Is Disrupting Marketing - Invest in the Shift
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SGRY is experiencing slight buying pressure.
Surgery Partners Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.83 | Sell |
20-day SMA: | 24.76 | Sell |
50-day SMA: | 23.31 | Buy |
200-day SMA: | 26.5 | Sell |
8-day EMA: | 23.9 | Sell |
20-day EMA: | 24.25 | Sell |
50-day EMA: | 24.08 | Sell |
200-day EMA: | 26.11 | Sell |
Surgery Partners Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 41.94 | Sell |
Chaikin Money Flow: | 57180 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.08 - 25.82) | Sell |
Bollinger Bands (100): | (20.85 - 28.17) | Sell |
Surgery Partners Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Surgery Partners Stock
Is Surgery Partners Stock a Buy?
-
Surgery Partners share price is 23.61 while SGRY 8-day simple moving average is 23.83, which is a Sell signal.
-
The stock price of SGRY is 23.61 while Surgery Partners 20-day SMA is 24.76, which makes it a Sell.
-
Surgery Partners 50-day simple moving average is 23.31 while SGRY share price is 23.61, making it a Buy technically.
-
SGRY stock price is 23.61 and Surgery Partners 200-day simple moving average is 26.50, creating a Sell signal.
SGRY Technical Analysis vs Fundamental Analysis
Sell
23
Surgery Partners (SGRY)
is a Sell
Is Surgery Partners a Buy or a Sell?
-
Surgery Partners stock is rated a SellThe current Surgery Partners [SGRY] share price is $23.61. The Score for SGRY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Surgery Partners Stock Info
Market Cap:
3B
Price in USD:
23.61
Share Volume:
819.6K
Surgery Partners 52-Week Range
52-Week High:
33.97
52-Week Low:
19.50
Sell
23
Surgery Partners (SGRY)
is a Sell
Surgery Partners Share Price Forecast
-
What is the Surgery Partners stock price today?The Surgery Partners stock price is 23.61 USD today.
-
Will SGRY stock go up or go down?Surgery Partners> share price is forecast to RISE/FALL based on technical indicators
-
Is Surgery Partners overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Surgery Partners is overvalued.
Is Surgery Partners Stock a Buy?
-
Surgery Partners share price is 23.61 while SGRY 8-day exponential moving average is 23.90, which is a Sell signal.
-
The stock price of SGRY is 23.61 while Surgery Partners 20-day EMA is 24.25, which makes it a Sell.
-
Surgery Partners 50-day exponential moving average is 24.08 while SGRY share price is 23.61, making it a Sell technically.
-
SGRY stock price is 23.61 and Surgery Partners 200-day simple moving average is 26.11, creating a Sell signal.
Fundamental Analysis of Surgery Partners
Is Surgery Partners a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.15 per share, and an increase next year of $0.34 per share.
Technical Analysis of Surgery Partners
Should I short Surgery Partners stock?
-
SGRY Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting Surgery Partners is a Sell
-
Surgery Partners Relative Strength Index (RSI) is 41.94, which suggest Surgery Partners is oversold
-
The Bollinger Bands (25) for Surgery Partners is (24.08 - 25.82), which suggest Surgery Partners is a Sell
-
The Bollinger Bands (100) for Surgery Partners is (20.85 - 28.17), which suggest Surgery Partners is a Sell
* Surgery Partners stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.